"Drug Liberation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Release of drugs from DOSAGE FORMS into solution.
| Descriptor ID |
D065546
|
| MeSH Number(s) |
G02.211 G03.787.321 G07.690.725.321
|
| Concept/Terms |
Drug Liberation- Drug Liberation
- Liberation, Drug
- Drug Release
- Release, Drug
- Drug Dissolution
- Dissolution, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Liberation".
Below are MeSH descriptors whose meaning is more specific than "Drug Liberation".
This graph shows the total number of publications written about "Drug Liberation" by people in this website by year, and whether "Drug Liberation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 3 | 3 |
| 2024 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Liberation" by people in Profiles.
-
Preparation and characterization of the injectable pH- and temperature-sensitive pentablock hydrogel containing human growth hormone-loaded chitosan nanoparticles via electrospraying. J Biomater Sci Polym Ed. 2024 Sep; 35(13):1999-2019.
-
Controlled Delivery of Rosuvastatin or Rapamycin through Electrospun Bismuth Nanoparticle-Infused Perivascular Wraps Promotes Arteriovenous Fistula Maturation. ACS Appl Mater Interfaces. 2024 Jul 03; 16(26):33159-33168.
-
Ultra-pH-sensitive nanoparticle of gambogenic acid for tumor targeting therapy via anti-vascular strategy plus immunotherapy. Int J Pharm. 2024 Jul 20; 660:124303.
-
Core-shell structured microneedles with programmed drug release functions for prolonged hyperuricemia management. J Mater Chem B. 2024 Jan 24; 12(4):1064-1076.
-
Formulation, Optimization, In Vitro and In Vivo Evaluation of Saxagliptin-Loaded Lipospheres for an Improved Pharmacokinetic Behavior. Biomed Res Int. 2021; 2021:3849093.
-
Ultra-long acting prodrug of dolutegravir and delivery system - Physicochemical, pharmacokinetic and formulation characterizations. Int J Pharm. 2021 Sep 25; 607:120889.
-
Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate? AAPS J. 2021 03 25; 23(3):48.
-
First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies. Invest New Drugs. 2021 08; 39(4):1047-1056.
-
Sustained delivery of a camptothecin prodrug - CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity. Int J Nanomedicine. 2019; 14:3799-3817.
-
A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage. Int J Pharm. 2018 Dec 01; 552(1-2):225-234.